FOI release

Freedom of Information request on the number of importation notifications with the total number of packs for Potassium chloride oral controlled release, Povidone-Iodine Ophthalmic & Sucralfate preparations (FOI 22/532)

Published 14 June 2022

FOI 22/532

25th April 2022

Dear

Thank you for your communication to the MHRA in relation to a Freedom of Information request for:

The number of MHRA importation notifications, as seen below, along with the total number of packs requested for the following products

  • Potassium chloride oral controlled release preparations
  • Povidone-Iodine Ophthalmic Preparations
  • Sucralfate Preparations
  • Diazoxide Preparations

From our preliminary assessment, it is clear that we will not be able to answer your request without further clarification.

The team requires further information in order to identify and locate the information you have asked for. Please, could you confirm the time period that you seek.

Once you have clarified your request, the twenty working day limit will recommence and we will begin to process the request. (Under section 1(3) of the Freedom of Information Act (FOIA), a public authority need not comply with a request unless any further information reasonably required to locate the information is supplied).

If you are dissatisfied with the handling of your request, you have the right to ask for an internal review. Internal review requests should be submitted within two months of the date of receipt of the response to your original letter and should be addressed to: Communications Directorate, Medicines and Healthcare products Regulatory Agency, 10 South Colonnade, Canary Wharf, London, E14 4PU. After that, if you remain dissatisfied, you may write to the Information Commissioner at;

Information Commissioner’s Office
Wycliffe House
Water Lane
Wilmslow
Cheshire
SK9 5AF

They will make a decision on whether or not we have interpreted the FOIA correctly in handling your request.

Yours sincerely

MHRA Customer Experience Centre